Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Atrial Fibrillation Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The atrial fibrillation market has experienced substantial expansion in recent years. This market is projected to grow from $15.1 billion in 2025 to $17.1 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.2%. The market’s growth in the past can be ascribed to the increasing prevalence of atrial fibrillation among aging populations, enhanced access to cardiac diagnostic technologies, a broader availability of anticoagulant therapies, the expansion of electrophysiology labs, and a heightened awareness of stroke prevention.
The atrial fibrillation market size is anticipated to undergo significant expansion over the next few years, with projections indicating it will reach $27.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This expected growth during the forecast period is driven by factors such as a rising demand for personalized arrhythmia treatments, the increasing embrace of wearable cardiac monitoring devices, the broadening scope of hybrid treatment approaches, growing investments in electrophysiology infrastructure, and an increased emphasis on achieving long-term rhythm management outcomes. Prominent trends observed in the forecast period include the expanding adoption of catheter ablation procedures, a greater reliance on advanced cardiac mapping systems, a growing preference for minimally invasive treatments, the development of pharmacological rhythm control therapies, and an enhanced focus on early diagnosis and continuous monitoring.
Get A Free Sample Report With In-Depth Market Insights:
Atrial Fibrillation Market Growth Backed By Core Demand Fundamentals
The rising incidence of cardiovascular diseases is projected to propel the atrial fibrillation market. These disorders, which impact the heart and blood vessels and include conditions like coronary artery disease, heart failure, and arrhythmias, represent a substantial threat to cardiovascular health. The increasing prevalence of these conditions necessitates sophisticated diagnostic and treatment options, thereby advancing the atrial fibrillation market as healthcare sectors address the escalating challenges. Supporting this, in October 2024, the CDC (Centers for Disease Control and Prevention), a U.S.-based government agency, reported that in 2023, 919,032 individuals succumbed to cardiovascular disease, accounting for 1 in every 3 deaths. Additionally, approximately 805,000 people in the United States experience a heart attack annually. Consequently, the global burden of cardiovascular diseases is a major impetus for the atrial fibrillation market.
Atrial Fibrillation Market Segment Analysis And Revenue Potential
The atrial fibrillation market covered in this report is segmented –
1) By Type: Surgical, Non-Surgical
2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies
3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion
4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers
Subsegments:
1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures
2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures
Atrial Fibrillation Market Growth Trends Reshaping The Competitive Landscape
Major companies within the atrial fibrillation market are introducing innovative products and solutions, such as patient-centric clinical decision support tools, to bolster their market position. Clinical decision support tools (CDST) are software or electronic systems designed to assist healthcare professionals in making well-informed and timely decisions regarding patient care. These tools are developed to integrate relevant clinical information from various sources. For instance, in August 2023, GE HealthCare, a US-based multinational medical technology company, launched CardioVisio, a patient-centered clinical decision support tool aimed at helping doctors provide evidence-based clinical decision support guided by current atrial fibrillation guidelines and visualize longitudinal data from diverse sources pertinent to illness progression. CardioVisio for atrial fibrillation can aid cardiologists in streamlining the interpretation of clinical images and providing a view of the patient’s heart history as well as their overall healthcare journey, including previous diagnoses, prescribed medications, interventions, and comorbidities.
Atrial Fibrillation Market Key Players Shaping Industry Direction
Major companies operating in the atrial fibrillation market are AtriCure Inc, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Sanofi SA, Bayer AG, Pfizer Inc, Daiichi Sankyo Company Limited, AstraZeneca PLC, Biotronik SE & Co KG, Kardium Inc, Acutus Medical Inc, Apama Medical Inc, CardioFocus Inc, AliveCor Inc, iRhythm Technologies Inc, BioSig Technologies Inc
View The Full Atrial Fibrillation Market Report:
Atrial Fibrillation Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the atrial fibrillation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.